Literature DB >> 13183997

The effect of barbiturates in patients with liver disease.

J T SESSIONS, H P MINKEL, J C BULLARD, F J INGELFINGER.   

Abstract

Entities:  

Keywords:  BARBITURATES/effects; LIVER/diseases

Mesh:

Substances:

Year:  1954        PMID: 13183997      PMCID: PMC438551          DOI: 10.1172/JCI102985

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

1.  The fate of pentobarbital in man and dog and a method for its estimation in biological material.

Authors:  B B BRODIE; J J BURNS; L C MARK; P A LIEF; E BERNSTEIN; E M PAPPER
Journal:  J Pharmacol Exp Ther       Date:  1953-09       Impact factor: 4.030

2.  THE ESTIMATION OF SERUM SODIUM FROM BICARBONATE PLUS CHLORIDE.

Authors:  P M Hald; A J Heinsen; J P Peters
Journal:  J Clin Invest       Date:  1947-09       Impact factor: 14.808

3.  THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN.

Authors:  S E Bradley; F J Ingelfinger; G P Bradley; J J Curry
Journal:  J Clin Invest       Date:  1945-11       Impact factor: 14.808

4.  An effect of barbiturates on serum cholinesterase.

Authors:  F Schütz
Journal:  J Physiol       Date:  1943-12-31       Impact factor: 5.182

5.  Measurement of serum cholinesterase activity in the study of diseases of the liver and biliary system.

Authors:  L J VORHAUS; H H SCUDAMORE; R M KARK
Journal:  Gastroenterology       Date:  1950-06       Impact factor: 22.682

6.  Further studies on factors influencing liver injury and liver repair.

Authors:  I S RAVDIN; H M VARS
Journal:  Ann Surg       Date:  1950-09       Impact factor: 12.969

  6 in total
  9 in total

1.  HEPATIC coma; presentation and discussion of case.

Authors: 
Journal:  Am J Dig Dis       Date:  1958-02

2.  To-day's Drugs.

Authors: 
Journal:  Br Med J       Date:  1963-01-05

3.  Safe prescribing in liver disease.

Authors: 
Journal:  Br Med J       Date:  1973-04-28

4.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

5.  [Pharmacokinetics of meprobamate in chronic liver diseases and drug addiction].

Authors:  H Held; H F von Oldershausen
Journal:  Klin Wochenschr       Date:  1969-01-15

6.  [The break-down of pentobarbital in hepatic diseases].

Authors:  H F von Oldershausen; H Held; H Remmer
Journal:  Klin Wochenschr       Date:  1970-05-01

7.  Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.

Authors:  J A Forrest; N D Finlayson; K K Adjepon-Yamoah; L F Prescott
Journal:  Br Med J       Date:  1977-05-28

Review 8.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

9.  Metabolism of amylobarbitone in patients with chronic liver disease.

Authors:  G E Mawer; N E Miller; L A Turnberg
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.